Joseph Wright - Mar 7, 2024 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
CHIEF COMMERCIAL OFFICER
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Stock symbol
MMSI
Transactions as of
Mar 7, 2024
Transactions value $
-$1,186,925
Form type
4
Date filed
3/8/2024, 03:40 PM
Previous filing
Mar 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Options Exercise $705K +25K +59.21% $28.20 67.2K Mar 7, 2024 Direct
transaction MMSI Common Stock, No Par Value Sale -$1.89M -25K -37.19% $75.68 42.2K Mar 7, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Options Exercise $0 -25K -100% $0.00* 0 Mar 7, 2024 Common Stock 25K $28.20 Direct F2
holding MMSI Non-qualified stock options (right to buy) 25K Mar 7, 2024 Common Stock 25K $44.80 Direct F3
holding MMSI Non-qualified stock options (right to buy) 30K Mar 7, 2024 Common Stock 30K $55.73 Direct F4
holding MMSI Non-qualified stock options (right to buy) 16.7K Mar 7, 2024 Common Stock 16.7K $37.71 Direct F5
holding MMSI Non-qualified stock options (right to buy) 9.68K Mar 7, 2024 Common Stock 9.68K $56.25 Direct F6
holding MMSI Non-qualified stock options (right to buy) 8.09K Mar 7, 2024 Common Stock 8.09K $65.03 Direct F7
holding MMSI Non-qualified stock options (right to buy) 13.6K Mar 7, 2024 Common Stock 13.6K $70.58 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.234 to $76.220, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2 Becomes exercisable in equal annual installments of 20% commencing on 04/14/2018.
F3 Becomes exercisable in equal annual installments of 20% commencing on 03/02/2019.
F4 Becomes exercisable in equal annual installments of 20% commencing on 03/01/2020.
F5 Becomes exercisable in equal annual installments of 25% commencing on 02/26/2021.
F6 Becomes exercisable in equal annual installments of 25% commencing on 03/19/2022.
F7 Becomes exercisable in equal annual installments of 25% commencing on 02/28/2023.
F8 Becomes exercisable in equal annual installments of 25% commencing on 02/28/2024.